Whole Exome and Whole Genome Sequencing (Non-Oncology Conditions) (for Kansas Only)
State-specific UnitedHealthcare medical policy (Kansas) governing coverage of whole exome sequencing (WES) and whole genome sequencing (WGS) for non-oncology (constitutional/heritable) conditions, directing readers to InterQual CP: Molecular Diagnostics for detailed medical necessity criteria and listing applicable procedure codes.
Revised coverage rationale language to indicate WES and WGS are proven and medically necessary in certain circumstances; refers to InterQual CP: Molecular Diagnostics topics (Hereditary Hearing Loss; WGS/WES/CMA for congenital or hereditary disorders).
Added procedure codes 0582U, 0583U, and 81354 to the Applicable Codes list.
Removed Definitions, Description of Services, Clinical Evidence, and References sections from the policy.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.